Chemoprophylaxis of malaria for travelers.
D000349:Africa; D000962:Antimalarials / Q000627:therapeutic use*; D001208:Asia; D002489:Central America; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D003622:Dapsone / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006115:Greece; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D010139:Pacific Islands; D010963:Plasmodium falciparum / Q000187:drug effects; D011319:Primaquine / Q000494:pharmacology / Q000627:therapeutic use; D012008:Recurrence; D013020:South America; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use; D013450:Sulfones / Q000494:pharmacology / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology / Q000627:therapeutic use; D014195:Travel; D014586:USSR
D000962:Antimalarials; D013449:Sulfonamides; D013450:Sulfones; D002738:Chloroquine; D003622:Dapsone; D013752:Tetracycline; D011319:Primaquine